Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calendula oil nanoemulsion with hydrocortisone for radiation-induced dermatitis in breast cancer
IRCT20240213061001N1Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydrocortisone in radiodermatitis and breast cancer, sponsored by North Khorasan University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
hydrocortisone
03
Conditions
radiodermatitisbreast cancer
Beyond the preview
Go deeper on IRCT20240213061001N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240213061001N1.